GeneDx Holdings Corp.
WGS
$107.20
-$1.15-1.06%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 16.40% | -8.96% | |||
| Total Other Revenue | 111.58% | -6.09% | |||
| Total Revenue | 17.88% | -8.91% | |||
| Cost of Revenue | 11.00% | -2.70% | |||
| Gross Profit | 21.25% | -11.67% | |||
| SG&A Expenses | -7.11% | 16.03% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.25% | 7.67% | |||
| Operating Income | 296.88% | -143.33% | |||
| Income Before Tax | 273.68% | -212.34% | |||
| Income Tax Expenses | -155.03% | 1,962.50% | |||
| Earnings from Continuing Operations | 265.55% | -220.06% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 265.55% | -220.06% | |||
| EBIT | 296.88% | -143.33% | |||
| EBITDA | 1,244.37% | -92.57% | |||
| EPS Basic | 263.02% | -218.55% | |||
| Normalized Basic EPS | 285.70% | -130.15% | |||
| EPS Diluted | 255.17% | -218.55% | |||
| Normalized Diluted EPS | 278.37% | -130.15% | |||
| Average Basic Shares Outstanding | 1.53% | 1.31% | |||
| Average Diluted Shares Outstanding | 5.71% | 1.31% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||